Articles mentioning POZEN Inc. (POZN)

Results 1 - 10 of 17 : 1 2 Next

Get RSS Feed for POZN

High-Growth Investing | April 28, 2008

FDA Moves Isis' Finish Line

Drugmaker Isis must complete cancer tests before submitting its marketing application.

High-Growth Investing | April 17, 2008

Headache Over for Pozen and Glaxo?

The duo's FDA headache is over, but a new one is about to begin.

Dividends & Income Investing | April 10, 2008

Glaxo Angers the FDA

Upsetting the agency that approves drugs is never a good move.

Dividends & Income Investing | February 20, 2008

Abbott's Copycat Combinations

FDA approval of a combination drug doesn't leave Merck trembling.

High-Growth Investing | January 16, 2008

Headache Almost Over for Pozen

The drug is safe; hopefully that's all the FDA wanted to know.

High-Growth Investing | October 16, 2007

Pozen Hedges Its Bets

Pozen plans a just-in-case safety trial.

Investing | October 11, 2007

Wednesday's Worst Stocks in the World

It had to be some company.

High-Growth Investing | October 08, 2007

Pozen Submits Safety Data

Will Pozen's response to its second approvable letter be enough?

High-Growth Investing | September 12, 2007

More Than Momentum: Stocks Rising for a Reason

Sorting a real growth story from a flash in the pan.

High-Growth Investing | August 17, 2007

Fewer Drug Approvals? Buy!

Stricter standards at the FDA could create a Foolish opportunity.

Results 1 - 10 of 17 : 1 2 Next

Get RSS Feed for POZN